GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » Other Current Liabilities

Egetis Therapeutics AB (OSTO:PLED BTA) Other Current Liabilities : kr150.80 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB Other Current Liabilities?

Egetis Therapeutics AB's other current liabilities for the quarter that ended in Mar. 2025 was kr150.80 Mil.

Egetis Therapeutics AB's quarterly other current liabilities increased from Sep. 2024 (kr120.60 Mil) to Dec. 2024 (kr145.40 Mil) and increased from Dec. 2024 (kr145.40 Mil) to Mar. 2025 (kr150.80 Mil).

Egetis Therapeutics AB's annual other current liabilities increased from Dec. 2022 (kr27.80 Mil) to Dec. 2023 (kr67.70 Mil) and increased from Dec. 2023 (kr67.70 Mil) to Dec. 2024 (kr145.40 Mil).


Egetis Therapeutics AB Other Current Liabilities Historical Data

The historical data trend for Egetis Therapeutics AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Other Current Liabilities Chart

Egetis Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.39 33.10 27.80 67.70 145.40

Egetis Therapeutics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.50 95.90 120.60 145.40 150.80

Egetis Therapeutics AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Egetis Therapeutics AB Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Egetis Therapeutics AB Business Description

Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines